MedPath

A prospective study for the effect of ferric citrate on FGF23 in patients with normophosphatemic CKD patients with iron deficiency.

Not Applicable
Completed
Conditions
chronic kidney disease
Registration Number
JPRN-UMIN000020935
Lead Sponsor
Department of Nephrology and Rheumatology, Saiseikai Niigata Daini Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

1)treatment with phosphate binder or iron supplementation 2) hypersensitivity to lanthanum carbonate and calcium carbonate 3) pregnancy or lactation 4) Any reason for ineligibility suggested by the attending doctor

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath